QNCXQuince Therapeutics, Inc.

Nasdaq quincetx.com


$ 0.92 $ 0.00 (0.03 %)    

Tuesday, 14-May-2024 15:05:53 EDT
QQQ $ 445.88 $ 1.10 (0.25 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.25 (0.43 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.87 (0.86 %)
$ 0.91
$ 0.93
$ 0.00 x 0
$ 0.00 x 0
$ 0.92 - $ 0.96
$ 0.84 - $ 1.74
59,201
na
39.56M
$ 0.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 10-29-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 06-12-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 quince-therapeutics-updates-pipeline-progress-eyes-enrollment-for-pivotal-phase-3-trial-in-ataxia-telangiectasia-reported-q1-eps-loss-of-026-cash-balance-of-678m

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company developing an innovative drug delivery technology d...

 quince-therapeutics-q4-eps-021-down-from-013-yoy

Quince Therapeutics (NASDAQ:QNCX) reported quarterly losses of $(0.21) per share. This is a 61.54 percent decrease over losses ...

 quince-therapeutics-reported-751m-in-cash-as-of-december-31-2023-expect-to-fully-fund-lead-asset-erydex-through-phase-3-neat-topline-results-and-prepare-for-a-potential-nda-submission-in-2026

Strong Cash Position Expected to Support Meaningful Clinical Milestone Reported $75.1 million in cash, cash equivalents, and...

 quince-therapeutics-on-dec-22-board-approved-certain-mutual-termination-of-license-agreement-by-and-between-co-purdue-research-foundation

-SEC Filing

 shf-holdings-and-3-other-stocks-under-2-insiders-are-buying

The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence...

 over-2m-bet-on-this-industrial-stock-check-out-these-4-penny-stocks-insiders-are-aggressively-buying

The Dow Jones closed higher by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidenc...

 why-glimpse-group-shares-are-trading-lower-by-around-41-here-are-20-stocks-moving-premarket

Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading.

 quince-therapeutics-and-2-other-stocks-under-3-insiders-are-buying

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence ...

 quince-therapeutics-q1-eps-014-up-from-051-yoy

Quince Therapeutics (NASDAQ:QNCX) reported quarterly losses of $(0.14) per share. This is a 72.55 percent increase over losses ...

 why-ryanair-holdings-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor i...

 whats-going-on-with-quince-therapeutics-stock-today

Quince Therapeutics Inc (NASDAQ: QNCX) has agreed to acquire EryDel SpA, a privately-held, late-stage biotech company, in a sto...

 quince-therapeutics-to-acquire-erydel-spa-and-its-phase-3-asset-targeting-ataxia-telangiectasia-involving-485m-in-potential-earnout

Quince Therapeutics, Inc. (NASDAQ:QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovati...

 echo-lake-capital-increase-offer-to-acquire-quince-therapeutics-for-180share

Earlier today Echo Lake Capital issued a letter to the Board of Directors of Quince Therapeutics, Inc. (NASDAQ:QNCX). The lette...

 reported-late-wednesday-april-5-quince-therapeutics-adopts-1-year-limited-duration-stockholders-rights-plan-and-declared-a-dividend-distribution-of-one-preferred-share-purchase-right-on-each-outstanding-share-of-quinces-common-stock

Quince Therapeutics, Inc. (NASDAQ:QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovati...

 quince-therapeutics-confirms-receipt-of-an-unsolicited-offer-from-echo-lake-capital

Quince's Board of Directors, consistent with its fiduciary responsibilities, will carefully review and evaluate the proposa...

 nasdaq-up-over-100-points-crude-oil-rises-2

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Do...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION